drugset / Trial / NCT02832089

Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation

NCT02832089

Phase 3 Completed 30 enrolled Andhra Medical College
NaSingle-groupOpen-labelTreatment

Summary

Oral carvedilol administered in escalating doses in patients with atrial fibrillation among patients with AF with fast ventricular rate.

Timeline

Start
2000-12
Primary completion
2002-03
Completion
2002-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 12.5 mg Oral

Indications